Possible use of the new antiretroviral drug a fixed-dose combination of TDF/RPV/FTC registered as Evipler for the treatment of HIV-1 infection (Record of the meeting)
- Authors: - -
- Issue: No 3 (2014)
- Pages: 79-80
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/278053
- ID: 278053
Cite item
Open Access
Access granted
Abstract
Full Text
References
Supplementary files
